Zelboraf (vemurafenib) - Roche
lifirafenib (BGB-283) - BeOne Medicines
Tafinlar (dabrafenib) - Novartis
ARQ 680 - Merck (MSD)
Ojemda (tovorafenib) - Day One Biopharma
http://www.ncbi.nlm.nih.gov/pubmed/41391260
 
Danting Zheng; Li Xu; Weichu Zhang
 
Dec 15, 2025
 
Next